Article

Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease

Clinical Division of Gastroenterology and Hepatology, Innsbruck Medical University, Innsbruck, Austria.
Hepatology (Impact Factor: 11.19). 08/2005; 42(2):466-72. DOI: 10.1002/hep.20775
Source: PubMed

ABSTRACT Ferroportin disease (hemochromatosis type 4) is a recently recognized disorder of human iron metabolism, characterized by iron deposition in macrophages, including Kupffer cells. Mutations in the gene encoding ferroportin 1, a cellular iron exporter, are responsible for this iron storage disease, inherited as an autosomal dominant trait. We present clinical, histopathological, and radiological findings in a family with the most common ferroportin mutation, V162del. In the index case, the disorder is characterized by abundant deposition of hemosiderin in all tissues investigated (mesenteric lymph node, liver, gastric and duodenal mucosa, and also in squamous cell carcinoma of the lung). The radiological findings indicated the presence of excess iron in bone marrow and spleen. Despite a significant burden of iron, no features of chronic liver disease were found in affected members of the family, including individuals aged up to 80 years. Hyperferritinemia greater than 1,000 microg/L was a penetrant biochemical finding before the second decade in life and was associated with significantly increased serum concentrations of pro-hepcidin that correlated positively with urinary hepcidin concentrations. In conclusion, the systemic iron burden in ferroportin disease is not a sufficient cause for chronic liver disease. In patients with most, but not all, ferroportin mutations, retention of iron in macrophages of the liver and other organs may protect against damage to parenchymal cells. Finally, macrophage iron storage in ferroportin disease is associated with elevated serum pro-hepcidin levels.

Download full-text

Full-text

Available from: David J Halsall, Sep 04, 2015
0 Followers
 · 
147 Views
 · 
248 Downloads
  • Source
    • "Of the transporter genes listed in Table 2, ''solute carrier family 39 (iron-regulated transporter), member 1'' (Slc40a1) encodes a multiple transmembrane domain protein, known as ferroportin 1, which acts as a cellular iron exporter in the liver (Anderson and Frazer, 2005). In humans, functional loss of Slc40a1 by mutation is reported to cause impaired iron homeostasis, resulting in iron overload and hemosiderin deposition in Kupffer cells (Zoller et al., 2005). Accordingly, the induction of Slc40a1 that we found may reflect a cellular effort to decrease the enhanced levels of intracellular iron, which was confirmed as hemosiderin deposition by histopathological analysis (Table 1) and was probably derived from heme degradation by Hmox1 (Fig. 5). "
    [Show abstract] [Hide abstract]
    ABSTRACT: A variety of pharmaceutical compounds causes hemolytic anemia as a significant adverse effect and this toxicity restricts the clinical utility of these drugs. In this study, we applied microarray technology to investigate hepatic gene expression changes associated with drug-induced hemolytic anemia and to identify potential biomarker genes for this hematotoxicity. We treated female Sprague-Dawley rats with two hemolytic anemia-inducing compounds: phenylhydrazine and phenacetin. Hepatic gene expression profiles were obtained using a whole-genome oligonucleotide microarray with pooled RNA samples from individual rats within each dose group and analyzed in comparison with hepatic histopathology, hematology, and blood chemistry data. We identified a small subset of genes that were commonly deregulated in all the severe hemolytic conditions, some of which were considered to be involved in hepatic events characteristic of hemolytic anemia, such as hemoglobin biosynthesis, heme metabolism, and phagocytosis. Among them, we selected six upregulated genes as putative biomarkers, and their expression changes from microarray measurements were confirmed by quantitative real-time PCR using RNAs from individual animals. They were Alas2, beta-glo, Eraf, Hmox1, Lgals3, and Rhced. Expression patterns of all these genes showed high negative and positive correlation against erythrocyte counts and total bilirubin levels in circulation, respectively, suggesting that these genes may be the potential biomarkers for hemolytic anemia. These findings indicate that drug-induced hemolytic anemia may be detected based on hepatic changes in the expression of a subset of genes that are mechanistically linked to the hematotoxicity.
    Toxicological Sciences 03/2007; 95(2):474-84. DOI:10.1093/toxsci/kfl152 · 4.48 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A modified optical interferometry technique was used to measure the EHD central film thickness of two oils up to pressures of 3.6 GPa. In order to generate such pressures a tungsten carbide ball was loaded against a hardened steel disc with a sapphire window insert. The results showed that the film thickness generated was slightly lower than that predicted by the Dowson-Hamrock equation and the load exponent lay between that predicted by Dowson-Hamrock and recent high pressure computed solutions.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Instant messaging (IM) systems are popular among users. Inside corporate environments, the real-time nature of IM communication has resulted in increased productivity. However, network administrators are concerned about the lack of security in ubiquitous IM systems and their potential to leak sensitive data to outsiders. In response, some corporate managers have banned the use of IM inside the organization. We advocate the adoption of IM usage policy that clarifies how security can be strengthened while maintaining realtime communication. It is hoped that the usage guidelines outlined in this paper will enable ubiquitous communication while maintaining security in IM environments.
    Wireless Telecommunications Symposium, 2005; 02/2005
Show more